Philippines Contraceptive Devices Market Report 2022 to 2030

Philippines Contraceptive Devices Market Analysis

$ 3999

The Philippines's Contraceptive Devices Market is expected to witness growth from $28 Mn in 2022 to $55 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. Modern contraceptive methods are increasingly in demand in the Philippines, especially among younger women and those who live in cities. This is influenced in part by the availability of knowledge about contraceptive alternatives and the growing awareness of the advantages of family planning. The market is segmented by type and by gender. Some key players in this market include United Laboratories, DKT Philippines, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10PHMD005 CATEGORY: Medical Devices GEOGRAPHY: Phillipines AUTHOR: Jigyasu Bhandari

Buy Now

Philippines Contraceptive Devices Healthcare Market Executive Analysis

The Philippines's Contraceptive Devices Market is expected to witness growth from $28 Mn in 2022 to $55 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. The Philippines experienced an increase in health spending from $16.12 billion in 2020 to $16.18 billion in 2023. As a result, at the current exchange rate, it made up 5.6% of the Gross Domestic Product (GDP). In the Philippines, household out-of-pocket costs accounted for about 41.5% of total health spending in 2021. By 2022, it was estimated that household health-related spending in the Philippines will equal $11.65 billion.

2.7 children were born to every woman in the Philippines, which is more than the average of 2.4 children per woman worldwide. 11% of women between the ages of 15 and 19 were discovered to be mothers. The rate of HIV infection in the Philippines is among the highest in Asia when it comes to STDs. In the Philippines in 2020, there were 7,700 persons with HIV and 8,300 new infections. In the Philippines, it is possible for individuals and couples to better plan and space their pregnancies with the use of contraceptive methods, which also lowers the risk of mother and newborn mortality and morbidity. By lowering the likelihood of unwanted pregnancies and unsafe abortions, as well as by enabling women to better plan and prepare for pregnancy and childbirth, access to contraceptive devices can contribute to improvements in maternal and child health outcomes. Some contraceptive methods, like condoms, can also aid in lowering the spread of sexually transmitted infections, a serious public health issue in the Philippines.

Philippines Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

Modern contraceptive methods are increasingly in demand in the Philippines, especially among younger women and those who live in cities. This is influenced in part by the availability of knowledge about contraceptive alternatives and the growing awareness of the advantages of family planning. Family planning is a top concern for the Philippine government, which has put in place a variety of laws and initiatives to improve access to reproductive health care, including contraceptive methods. This involves carrying out the Responsible Parenthood and Reproductive Health Law, which demands that low-income families receive free and subsidised contraceptive devices. In the Philippines, the demand for contraceptive devices that can help women plan and space their pregnancies and combine their job and family obligations is rising in the Philippines as more women join the workforce.

Market Restraints

In the Philippines, there are still sizable access gaps to reproductive health care despite government efforts to improve access, especially in rural and isolated areas. As a result, there may be a decrease in the demand for contraceptive methods and it may be more challenging for producers to contact these consumers. Due to cultural or religious attitudes that consider contraception as sinful or unsuitable, some portions of the Filipino population may be reluctant to use contraceptive methods. This may reduce overall demand for certain goods and make it more difficult for manufacturers to promote and advertise their devices.

Competitive Landscape

Key Players

United Laboratories (PH)
DKT Philippines (PH)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

In the Philippines, the Food and Drug Administration (FDA), which is in charge of regulating and overseeing the safety, efficacy, and quality of, contraceptive devices, is in charge of the regulatory environment in the Philippines market for contraceptive devices. Contraceptive devices must adhere to a set of rules and regulations established by the FDA for approval and registration that must be met before they can be sold on the market. The Philippine government has prioritised family planning and reproductive health in its healthcare policy and has put in place a number of laws and initiatives targeted at enhancing access to these services. The Responsible Parenthood and Reproductive Health (RPRH) Law, which was passed in 2012, requires that low-income families receive free and subsidised contraceptive devices.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.